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Conclusions. The incidence and prevalence of thyrotoxic heart failure (THF) provide a wide 
variation from 12% to 68% in hyperthyroid patients. Up to 90% of patients with thyrotoxicosis 
may develop Atrial Fibrillation, 47% Left Ventricle systolic dysfunction and 1% dilated THF 
and a third of these cases are reversible. Mortality in THF patients is 1.2 higher than in patients 
with hypertension, valvular heart disease or coronary artery disease, and 1.4 higher than in the 
general population. Hyperthyroidism is a potentially reversible and curable cause of THF, so 
it should be excluded in every new patient with HF, especially in young patients and in the 
absence of coronary artery disease and other structural heart diseases.  
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Introduction. Atrial fibrilation is the most common cardiac arrhythmia with the worldwide 
prevalence of more than 33.5 million people and is a subject with increased interest in clinical 
trials. The reason is the awareness of the high risk of embolic events that in 75 % are 
complicated by cerebrovascular accidents. It is estimated that the number of patients with AF 
in 2030 in Europe will be 14–17 million and the number of new cases of AF per year at 
120,000–215,000. In approximately 80% of patients, atrial fibrillation is associated with 
organic heart disease including valvular heart disease (mostly mitral valve disease), coronary 
artery disease, hypertension, hypertrophic or dilated cardiomyopathy. In 20% of cases, atrial 
fibrillation occurs in the absence of organic heart disease. Besides the danger of embolic events, 
atrial fibrillation is the most common atrial arrhythmia found in Brugada syndrome which is 
associated with malignant ventricular arrhythmias and sudden cardiac death.  
Aim of the study. The purpose of this study was to review data about characteristics and 
management of atrial fibrillation in Brugade syndrome.  
Materials and methods. The source of information was represented by articles published in 
the online databases: PubMed, HINARI, SCOPUS, EMBASE 
Results. Current evidence revealed that the prevalence of AF in patients in BrS vastly differs 
among publish studies, ranged from 6% to 39%. The only genetic mechanism of arrhythmias 
is related to the mutation of the SCN5A gene that encodes cardiac sodium channels. However, 
as this sodium channel is found not only in the ventricular tissue, but also in the atria, this could 
lead to reentrant tachyarrhythmias in the atrium. Nevertheless, management of BrS with AF 
remains a difficult task, as medication for AF, such as sodium channel blockers, confers their 
risk owing to their proarrhythmic effects in patients with BrS. In addition, other than quinidine 
and disopyramide cannot be used because they block sodium channels and cause ventricular 
arrhythmias. Recent evidence suggested that catheter ablation could be utilized as a first‐line 
therapy for paroxysmal AF in BrS patients. For the last 2 decades, ICD therapy has been 
considered as the cornerstone therapy of patients with documented ventricular 
tachyarrhythmia, but recent studies has been associated ICD therapy with a significant rate of 
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complications, and should be avoided in asymptomatic patients. The most common of these 
complications are inappropriate shocks, which cause pain, and can produce psychological 
trauma. Pulmonary vein isolation (PVI) is an effective method for controlling paroxysmal AF. 
The literature indicates that the success rate of PVI is 79.8% in the long term in patients with 
brugada syndrome.  
Conclusions. According to studies, PVI has been shown to have minimal risk of complications 
and is considered one of the most effective long-term methods in the control of atrial fibrillation 
and brugade syndrome. This treatment method could be considered the first line of treatment 
for atrial fibrillation and in brugade syndrome.  
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Background. Wellens’ syndrome consists of particular T-wave changes in the precordial leads 
on ECG accompanied by severe proximal left anterior descending artery stenosis, and is often 
associated with sudden cardiac death and acute myocardial infarction. It is a pre-infarction 
state. However, this syndrome is not always an acute process.  There are two ECG patterns of 
Wellens syndrome. Type-A: up sloping ST waves, no or mild ST elevation at the J point and 
biphasic T waves, with initial positivity and terminal negativity. These T wave findings are 
present in about 25% of cases. Type-B: symmetrical deeply inverted T waves, in approximately 
75% of cases. Both types, R waves preserved in the precordial leads  
Case report. A 65-year-old male patient, was admitted in the Intensive Care Unit of MCH 
“Holy Trinity” with Non-STE ACS. Complaining on angina: burning chest pain felt as well in 
the neck and lower jaw, occurring at mild exertion lasting for ≥40min and relieved by i/v 
nitrates. Other complains: shortness of breath at mild exertion and fatigue. History: his 
condition worsened for about 5 days ago while being on a ski resort in Ukraine and felt for the 
first time angina chest pain lasting about 1h. He was admitted in the ICU of the Regional non-
PCI hospital and acute MI diagnose was established, based on a troponin I test – 3,14ng/ml. 
Because of high costs of the medical care he left the hospital and came back to Moldova by 
car. During the long trip (5h) he felt several angina episodes, the longest lasting about 40min. 
ECG at admission: sinus rhythm, normal axis, HR = 76 bpm, up slopping ST segment in V2-  
V4, ST elevation at the J point max 0,5 mm in V3, biphasic T waves in V2-V4 initially positive 
than negative. Echography: no wall motion abnormality revealed, EF 58%. Serum troponin T 
– 0.21 ng/ml (0,3ng ml reference limit), CK-MB - 17 U/l (reference limit 24 U/l).  Coronary 
angiography: two-vessel disease, sub occlusive stenosis of proximal LAD (99%), severe on 
RCA (75-90%). PCI of the culprit lesion with one DES of new generation was performed 
successfully and the second PCI on RCA scheduled in two weeks (aiming complete 
revascularization). ECG on the second day following PCI showed no biphasic T-waves in the 
precordial leads. At 1 month after the complete revascularization, the patient has no symptoms 
even at intense exertion.  
